Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
N
Nectar Lifesciences Ltd
Score 68/100• Decent
Nectar Lifesciences Ltd shows potential in a growing sector, but faces challenges in consistency and valuation, warranting cautious observation.
Company’s Health27/100
Valuation 100/100 · PB 0.3638
Technical Avoid
1M 11.623% 6M -28.918% 1Y -58.859%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#76
View details ➜
M
Makers Laboratories Ltd
Score 68/100• Decent
Makers Laboratories Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health64/100
Valuation 100/100 · PB 0.6241
Technical Avoid
1M -3.731% 6M -13.612% 1Y -21.107%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#77
View details ➜
L
Laurus Labs Ltd
Score 68/100• Decent
Laurus Labs Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics.
Company’s Health68/100
Valuation 20/100 · PB 11.1853
Technical Momentum
1M 13.831% 6M 53.678% 1Y 94.127%
Confidence100%
Weak ROEPromoter pledge present
#78
View details ➜
J
Jubilant Pharmova Ltd
Score 68/100• Decent
Jubilant Pharmova Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health54/100
Valuation 60/100 · PB 2.7932
Technical Avoid
1M 3.594% 6M 21.396% 1Y -9.14%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#79
View details ➜
J
Jagsonpal Pharmaceuticals Ltd
Score 68/100• Decent
Jagsonpal Pharmaceuticals Ltd shows potential but faces significant challenges in profitability and valuation metrics. Caution is advised for investors.
Company’s Health94/100
Valuation 20/100 · PB 6.1967
Technical Avoid
1M 0.429% 6M -5.556% 1Y 2.653%
Confidence100%
Low leverage (D/E)No promoter pledge
#80
View details ➜
J
J B Chemicals and Pharmaceuticals Ltd
Score 68/100• Decent
J B Chemicals and Pharmaceuticals Ltd shows decent potential with a stable growth outlook, but investors should be cautious of execution risks and valuation metrics.
Company’s Health95/100
Valuation 20/100 · PB 7.6731
Technical Avoid
1M 0.341% 6M 6.691% 1Y -14.214%
Confidence100%
Low leverage (D/E)No promoter pledge
#81
View details ➜
I
IPCA Laboratories Ltd
Score 68/100• Decent
IPCA Laboratories Ltd shows potential for growth, but investors should be cautious due to profitability inconsistencies and valuation concerns.
Company’s Health80/100
Valuation 40/100 · PB 3.8448
Technical Avoid
1M -3.67% 6M -7.764% 1Y -19.99%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#82
View details ➜
I
Indoco Remedies Ltd
Score 68/100• Decent
Indoco Remedies Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health56/100
Valuation 60/100 · PB 2.5263
Technical Avoid
1M -3.425% 6M 21.549% 1Y -10.068%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#83
View details ➜
H
Hindustan Bio Sciences Ltd
Score 68/100• Decent
Hindustan Bio Sciences Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health33/100
Valuation 20/100 · PB 8.4512
Technical Avoid
1M -13.976% 6M -9.842% 1Y -32.972%
Confidence100%
No promoter pledgeHealthy profit margins
Weak ROEHigh debt/equity
#84
View details ➜
G
Gufic Biosciences Ltd
Score 68/100• Decent
Gufic Biosciences Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
Company’s Health90/100
Valuation 20/100 · PB 5.429
Technical Avoid
1M -8.696% 6M -9.874% 1Y -25.784%
Confidence100%
No promoter pledge
#85
View details ➜
F
Fortis Healthcare Ltd
Score 68/100• Decent
Fortis Healthcare Ltd shows potential in a growing sector but faces challenges in execution and competition. Caution is advised.
Company’s Health67/100
Valuation 20/100 · PB 8.4232
Technical Watch
1M 7.58% 6M 50.759% 1Y 63.767%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#86
View details ➜
D
Dr Lalchandani Labs Ltd
Score 68/100• Decent
Dr Lalchandani Labs Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics. Caution is advised.
Company’s Health46/100
Valuation 100/100 · PB 0.989
Technical Avoid
1M 9.268% 6M 84.219% 1Y 15.758%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#87
View details ➜
D
DocMode Health Technologies Ltd
Score 68/100• Risky
DocMode Health Technologies Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health44/100
Valuation 40/100 · PB 4.6201
Technical Momentum
1M 52.728% 6M 124.817% 1Y 50.061%
Confidence100%
Weak ROEPromoter pledge present
#88
View details ➜
C
Concord Biotech Ltd
Score 68/100• Decent
Concord Biotech Ltd shows potential for growth but faces challenges in valuation and execution risks.
Company’s Health94/100
Valuation 20/100 · PB 8.3325
Technical Avoid
1M -11.858% 6M -3.14% 1Y -21.117%
Confidence100%
Low leverage (D/E)No promoter pledge
#89
View details ➜
B
Bharat Parenterals Ltd
Score 68/100• Decent
Bharat Parenterals Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health64/100
Valuation 60/100 · PB 2.4589
Technical Avoid
1M -1.339% 6M 22.431% 1Y -17.682%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#90
View details ➜
Showing 76 to 90 of 260 (18 Pages)